Alarge volcano that expels large amounts of flowing lava is a

5submission this assignment is worth 20 points total. you are required to submit the following by next lab: 1. (3 points) determine the equation for the output angular velocity ω2 = θ˙ 2 as a function of θ1, ω1 = θ˙ 1 and α. you must show all your work to receive credit. 2. (2 points) use the result of problem#1 to plot ω2 over 0 ≤ θ1 ≤ 360deg with ω1 = 360deg/sec. do this for α = {10,30}deg. show the results on the same plot and properly label the axes, title, legend. for this you can use matlab or ms excel. 3. (3 points) determine the equation for the output angular acceleration ω˙ 2 and create a plot similar to the one in problem#2. 4. (10 points) submit plots of the results (ω2 and ω˙ 2) obtained from creo/mechanism and compare them to results of problem#2 and problem#3. note that you should do these comparisons for the two cases with α = {10,30}deg. 5. (2 points) provide a brief explanation of the results. did they match? what are the implications as misalignment angle increases?

Samir watches a 100-minute movie on his spaceship. maria's spaceshipe flies in the same direction as samir's spaceship but she observes his move to last 125 minutes and his spaceship to be 40 m long. how long does samir observe his own spaceship to be? according to an observer on earth, planet x is stationary. maria and samir depart earth on their spaceships at the same time, each flying at 0.5c. maria flies toward planet x and samir flies in the opposite direction. according to maria, her voyage to planet x takes 9 years. how many years does marias voyage take according to samir?

Asubject in a clinical research trial experiences a serious, unanticipated adverse drug experience. how should the investigator proceed, with respect to the irb, after the discovery of the adverse event occurrence? a. do not report the adverse drug experience to the irb since it is a common adverse experience.b. report the adverse drug experience to the irb only if there are several other occurrences.c. report the adverse drug experience as part of the continuing review report.d. report the adverse drug experience in a timely manner, in keeping with the irb's policies and procedures, using the forms or the mechanism provided by the irb.